For people born with Lynch syndrome, cancer prevention has traditionally meant surveillance: frequent colonoscopies, genetic counseling and, in some cases, preventive surgery. Now researchers are testing a different idea. A Lynch syndrome vaccine could train the immune system to recognize abnormal cells before they develop into colorectal cancer. The approach is still experimental, but a 2026 study has provided some of the clearest evidence yet that a preventive cancer vaccine can generate
